Drontal Dog Tasty Bone 150/144/50 mg tablets

国: アイルランド

言語: 英語

ソース: HPRA (Health Products Regulatory Authority)

有効成分:

Febantel; Pyrantel embonate ; Praziquantel

から入手可能:

Vetoquinol SA

ATCコード:

QP52AC55

INN（国際名）:

Febantel; Pyrantel embonate ; Praziquantel

投薬量:

150,144,50 mg/tablet

医薬品形態:

Tablet

処方タイプ:

CAM: Companion Animal Medicine as defined in relevant national legislation

治療領域:

febantel, combinations

認証ステータス:

Authorised

承認日:

2014-10-24

製品の特徴

Health Products Regulatory Authority
16 October 2020
CRN009Z91
Page 1 of 5
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Drontal Dog Tasty Bone 150/144/50 mg tablets
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
​
Each tablet contains:
​
​
​
​
ACTIVE SUBSTANCES
​
​
150 mg febantel
​
​
50 mg pyrantel equivalent to 144 mg pyrantel embonate
​
​
50 mg praziquantel
​
​
​
​
EXCIPIENTS
​
​
For the full list of excipients, see section 6.1.
​
3 PHARMACEUTICAL FORM
Tablet.
A light-brown to brown, meat flavoured, bone shaped tablet scored on
both sides that can be divided into halves.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Dogs.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Treatment of mixed infections by nematodes and cestodes of the
following species:
Roundworms:
Ascarids (adult and late immature forms):
_Toxocara canis_
_Toxascaris leonina_
Hookworms (adults):
_Uncinaria stenocephala_
_Ancylostoma caninum_
Whipworms (adults):
T_richuris vulpis_
Tapeworms (adult and immature forms):
_ Echinococcus granulosus_
_ Echinococcus multilocularis_
_Dipylidium caninum_
_Taenia spp._
4.3 CONTRAINDICATIONS
Do not use in cases of hypersensitivity to the active substances or to
any of the excipients.
Do not use during the 1st and 2nd third of pregnancy (see section
4.7).
Health Products Regulatory Authority
16 October 2020
CRN009Z91
Page 2 of 5
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
Fleas serve as intermediate hosts for one common type of tapeworm -
_Dipylidium caninum_. Tapeworm infestation is certain to
re-occur unless control of intermediate hosts such as fleas, mice etc.
is undertaken.
4.5 SPECIAL PRECAUTIONS FOR USE
Special precautions for use in animals
Parasite resistance to any particular class of anthelmintic may
develop following frequent, repeated use of an anthelmintic of
that class.
To minimise the risk of reinfestation and new infestation, excreta
should be collected and properly disposed of for 24 hours
following treatment.
Special preca